BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 21075557)

  • 21. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.
    Kharofa J; Choong N; Wang D; Firat S; Schultz C; Sadasiwan C; Wong S
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):690-5. PubMed ID: 22112556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma.
    Daly ME; Lieskovsky Y; Pawlicki T; Yau J; Pinto H; Kaplan M; Fee WE; Koong A; Goffinet DR; Xing L; Le QT
    Head Neck; 2007 Mar; 29(3):211-20. PubMed ID: 17111429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation therapy for patients of malignant salivary gland tumors with positive surgical margins.
    Sakata K; Aoki Y; Karasawa K; Nakagawa K; Hasezawa K; Muta N; Terahara A; Onogi Y; Sasaki Y; Akanuma A
    Strahlenther Onkol; 1994 Jun; 170(6):342-6. PubMed ID: 8023243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of nasopharyngeal salivary gland malignancy.
    Schramm VL; Imola MJ
    Laryngoscope; 2001 Sep; 111(9):1533-44. PubMed ID: 11568602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
    Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adenoid cystic carcinoma of the head and neck: a retrospective series of 169 cases].
    Dubergé T; Bénézery K; Resbeut M; Azria D; Minsat M; Ellis S; Teissier E; Zaccariotto A; Champetier C; Cowen D
    Cancer Radiother; 2012; 16(4):247-56. PubMed ID: 22652299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
    McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinomas arising in the submandibular gland: high propensity for systemic failure.
    Roh JL; Choi SH; Lee SW; Cho KJ; Nam SY; Kim SY
    J Surg Oncol; 2008 May; 97(6):533-7. PubMed ID: 18286522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
    Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
    Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
    Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
    Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
    Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Dirix P; Vanstraelen B; Jorissen M; Vander Poorten V; Nuyts S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):998-1004. PubMed ID: 20338694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
    Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma.
    Tanvetyanon T; Qin D; Padhya T; McCaffrey J; Zhu W; Boulware D; DeConti R; Trotti A
    Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):687-92. PubMed ID: 19620591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
    Lee NY; de Arruda FF; Puri DR; Wolden SL; Narayana A; Mechalakos J; Venkatraman ES; Kraus D; Shaha A; Shah JP; Pfister DG; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):966-74. PubMed ID: 17145527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors and outcome analysis of submandibular gland cancer: a clinical audit.
    Mallik S; Agarwal J; Gupta T; Kane S; Laskar SG; Budrukkar A; Murthy V; Goel V; Jain S
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2104-10. PubMed ID: 20538399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.